semaglutide and water retention Does Reduce Edema? GLP-1 Fluid does semaglutide cause water retention

Baseline demographics by age group show that 24% were aged 45-54, 38% aged 55-64, 30% aged 65-74 and 8% aged 75 years plus

Annals of the New York Academy of Sciences, 1269 (1), 92-100

WeightWatchers chooses Novo Nordisk's obesity drug in tablet form The collaboration is a potential win for WeightWatchers, which is recovering from bankruptcy

Major players Novo Nordisk: Semaglutide franchise, advancing into amylin combos (CagriSema) Eli Lilly and Company: Tirzepatide (marketed), Retatrutide (triple agonist), Orforglipron (oral GLP-1) Amgen, Boehringer Ingelheim / Zealand Pharma, Altimmune, Inc., @Roche (via Carmot): all pushing dual and triple incretin strategies with unique angles like NASH benefits or monthly dosing